Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Geron Corporation GERN

Sector: Healthcare | Sub-Sector: Biotechnology

Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.
Price: $2.38 | Change: $0.00 | %Change: 0.00%
Volume: 1.7m | Day High/Low: 2.43/2.35 | 52 Week High/Low: 7.79/1.39

Snapshot

Last Traded: September 02, 2014 10:00 Transaction Volume: 1.7m
Open: $2.38 Previous Close: $2.38
Bid: $2.38 Ask: $2.39
Bid Size: 4,400 Ask Size: 2,300
Market Cap: $373.4m Shares Out: 156.9m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Stock picks including a coal play

Some pharma recommendations also provided

J.W. Cotton   November 4, 2009
0 stars

Profiting from the 'picks and shovels' of stem cell research

When a race is fueled by hope and greed, failure and economic ruin usually waits at the finish line

Andrew Mickey   January 27, 2009
0 stars

Make money from the next emerging boom

Surprising company keeps reinventing itself

Andrew Mickey   November 25, 2008
0 stars

Cash-rich companies for the bear-market bounce

Dow headed back to 11,000 by year end

Jason Schwarz   November 7, 2008
0 stars

Latest Bullboard Posts